Schedule 13G ownership disclosure

Vir Biotechnology Inc

COMMON STOCK · CUSIP: 92764N102

Event date: 2026-09-30

Filing-level shares
7,822,781.00
Percent of class
4.6%
  • STATE STREET CORPORATION

    Shares: 7,822,781.00 · Class: 4.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000742
Form type
SCHEDULE 13G
Filer
Vir Biotechnology, Inc.
CIK
CIK 1706431
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub